Reinstatement

Pharmaceutical Development of Novel Lactate-based 6-fluoro-l-DOPA Formulations

Reinstatement Details

Nature of Retraction:

Reinstatement

Retraction Notice:
10.1016/j.ejps.2016.10.001
Additional Notes:

Pubmed had Temporary Removal attached to this title as of 12/2016. No dates provided for replaced article.

Citations (7)

7
Total Citations
7
Post-Retraction
(100.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
5 After 2+ years
2738 Days since retraction (latest)
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Apr 2024
2738 days after retraction
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Aug 2023
2493 days after retraction
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Nov 2022
2235 days after retraction
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Aug 2021
1767 days after retraction
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Feb 2019
870 days after retraction
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Jan 2018
454 days after retraction
Paper citing Pharmaceutical Development of Novel Lactate-based ...
Unknown Authors
Unknown Journal
Published: Aug 2017
322 days after retraction
Quick Stats
Total Citations: 7
Years Since Retraction: 9.1 years
Open Access: Yes
Last Checked: Never
Related Papers
Pharmacological Properties of Bergapten: Mechanistic and Th…
Oxidative Medicine and Cellular Longevity • 62 citations
Memantine Enhances the Inhibitory Effects of Naltrexone on …
European Journal of Pharmacology • 9 citations
MicroRNA-155 regulates human angiotensin II type 1 receptor…
The Journal of Biological Chemistry • 54 citations